Oscar Health, Inc.
OSCR
$13.58
-$0.47-3.35%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 54.48% | 56.76% | 51.39% | 45.79% | 46.99% |
| Total Other Revenue | -12.34% | -3.64% | -9.26% | -38.23% | -57.06% |
| Total Revenue | 54.26% | 56.54% | 51.12% | 45.19% | 45.80% |
| Cost of Revenue | 57.44% | 57.96% | 49.77% | 40.41% | 40.34% |
| Gross Profit | 42.91% | 51.12% | 56.36% | 64.94% | 69.35% |
| SG&A Expenses | 29.74% | 23.13% | 35.32% | 43.47% | 60.85% |
| Depreciation & Amortization | -7.45% | 4.73% | 33.56% | 135.07% | 579.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.10% | 49.55% | 41.87% | 32.32% | 30.44% |
| Operating Income | 783.74% | 124.30% | 119.04% | 111.11% | 95.48% |
| Income Before Tax | 379.53% | 112.51% | 110.60% | 105.06% | 91.04% |
| Income Tax Expenses | 737.99% | 121.77% | 103.93% | 571.58% | 12,042.11% |
| Earnings from Continuing Operations | 332.12% | 109.65% | 108.51% | 103.84% | 90.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -678.85% | -414.18% | -208.22% | -111.76% | -110.78% |
| Net Income | 330.15% | 109.39% | 108.35% | 103.83% | 90.61% |
| EBIT | 783.74% | 124.30% | 119.04% | 111.11% | 95.48% |
| EBITDA | 2,152.58% | 143.63% | 131.54% | 119.28% | 101.67% |
| EPS Basic | 288.92% | 113.14% | 107.30% | 102.18% | 90.33% |
| Normalized Basic EPS | 326.68% | 115.74% | 109.10% | 103.27% | 90.69% |
| EPS Diluted | 153.07% | 93.26% | 96.38% | 94.29% | 84.98% |
| Normalized Diluted EPS | 173.70% | 97.45% | 95.29% | 93.37% | 84.57% |
| Average Basic Shares Outstanding | 8.91% | 8.45% | 7.51% | 6.48% | 5.23% |
| Average Diluted Shares Outstanding | 14.31% | 22.85% | 22.11% | 21.24% | 12.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |